drugset / Trial / NCT00139113

Immunogenicity Study of an Inactivated Hepatitis A Vaccine in Infants and Young Children

NCT00139113

RandomizedSingle-groupSingle-blindPrevention

Summary

Infants born to immune mothers and therefore having passively-transferred maternal antibody (PMA) to hepatitis A virus (HAV) have a blunted immune response to hepatitis A vaccine. We compared the immunogenicity of hepatitis A vaccine among infants with and without PMA, vaccinated on different schedules. We found that when vaccination is begun at or after 12 months of age, there was no difference in the immune response to the vaccine between infants born to immune vs. susceptible mothers.

Timeline

Start
1996-09
Primary completion
2001-06
Completion
2001-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Havrix Vaccine 720 unknown